237 related articles for article (PubMed ID: 38642693)
1. A review of DNA nanoparticles-encapsulated drug/gene/protein for advanced controlled drug release: Current status and future perspective over emerging therapy approaches.
Kashani GK; Naghib SM; Soleymani S; Mozafari MR
Int J Biol Macromol; 2024 May; 268(Pt 1):131694. PubMed ID: 38642693
[TBL] [Abstract][Full Text] [Related]
2. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
4. Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers.
Sharifi S; Caracciolo G; Mahmoudi M
Trends Pharmacol Sci; 2020 Sep; 41(9):641-652. PubMed ID: 32713606
[TBL] [Abstract][Full Text] [Related]
5. Cancer nanomedicine: from targeted delivery to combination therapy.
Xu X; Ho W; Zhang X; Bertrand N; Farokhzad O
Trends Mol Med; 2015 Apr; 21(4):223-32. PubMed ID: 25656384
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine: An effective tool in cancer therapy.
Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
[TBL] [Abstract][Full Text] [Related]
7. BODIPY-loaded polymer nanoparticles: chemical structure of cargo defines leakage from nanocarrier in living cells.
Trofymchuk K; Valanciunaite J; Andreiuk B; Reisch A; Collot M; Klymchenko AS
J Mater Chem B; 2019 Aug; 7(34):5199-5210. PubMed ID: 31364614
[TBL] [Abstract][Full Text] [Related]
8. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
9. A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers.
Kucuksayan E; Bozkurt F; Yilmaz MT; Sircan-Kucuksayan A; Hanikoglu A; Ozben T
Sci Rep; 2021 Jun; 11(1):13027. PubMed ID: 34158544
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
12. Smart surface coating of drug nanoparticles with cross-linkable polyethylene glycol for bio-responsive and highly efficient drug delivery.
Wei W; Zhang X; Chen X; Zhou M; Xu R; Zhang X
Nanoscale; 2016 Apr; 8(15):8118-25. PubMed ID: 27025546
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
Shi J; Xiao Z; Kamaly N; Farokhzad OC
Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
[TBL] [Abstract][Full Text] [Related]
14. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
15. Rectorite-intercalated nanoparticles for improving controlled release of doxorubicin hydrochloride.
Jin J; Tu H; Chen J; Cheng G; Shi X; Deng H; Li Z; Du Y
Int J Biol Macromol; 2017 Aug; 101():815-822. PubMed ID: 28315438
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles as Adjuvants in Vaccine Delivery.
Garg A; Dewangan HK
Crit Rev Ther Drug Carrier Syst; 2020; 37(2):183-204. PubMed ID: 32865905
[TBL] [Abstract][Full Text] [Related]
17. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
18. Engineered bovine serum albumin-based nanoparticles with pH-sensitivity for doxorubicin delivery and controlled release.
Yang Z; Zhang N; Ma T; Liu L; Zhao L; Xie H
Drug Deliv; 2020 Dec; 27(1):1156-1164. PubMed ID: 32755291
[TBL] [Abstract][Full Text] [Related]
19. The key role of the drug self-aggregation ability to obtain optimal nanocarriers based on aromatic-aromatic drug-polymer interactions.
Villamizar-Sarmiento MG; Guerrero J; Moreno-Villoslada I; Oyarzun-Ampuero FA
Eur J Pharm Biopharm; 2021 Sep; 166():19-29. PubMed ID: 34052430
[TBL] [Abstract][Full Text] [Related]
20. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]